Show pageBacklinksCite current pageExport to PDFBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. antibodies: [[rituximab]] (Rituxan®) especially for disease relapse. [[Belimumab]] (Benlysta®) is under investigation. Belimumab, sold under the brand name Benlysta, is a human monoclonal antibody that inhibits B-cell activating factor, also known as B-lymphocyte stimulator. It is approved in the United States, Canada, and the European Union to treat systemic lupus erythematosus belimumab.txt Last modified: 2024/06/07 03:00by 127.0.0.1